ArticlemHealth2024
Mobile health and behavior tracking (mHBT) among cancer survivors: results from a large and diverse sample.
Article in mHealth, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Correlates of Fitness Tracker Ownership and Use in Cancer Survivors: Cross-Sectional Survey.JMIR cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the prevalence of mobile health and behavior tracking (mHBT) among a large and diverse sample of cancer survivors in the United States focusing on different mHBT adoption based on socio-demographic factors. Data was drawn from the 2020 to 2021 Health Information National Trends Survey (HINTS), which over-sampled cancer survivors from three cancer registries. Data analyses revealed that out of 1,234 cancer survivors studied, 39% had adopted mHBT, with 52% of these users engaging in daily tracking. A significant majority (86%) mHBT users were willing to share their data with healthcare providers. Notably, mHBT adoption was independently associated with younger age, female gender, college education, and better perceived health; but it was not significantly associated with race, income level, or state of residence after controlling for confounders. Cancer survivors' high rates of mHBT use and willingness to share data suggest the potential of using patient-generated data for personalized care and monitoring. However, caution is needed to address the digital divide and its impact on health disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.